- Varian is a global leader in the field of radiation therapy with around 50% market share.
- The radiation therapy market is a growing market, driven by an increasing cancer rate globally and increasing adoption of radiation therapy in emerging markets.
- Varian is a very innovative company, driving business growth through successful product launches and gaining market share.
- It is well positioned to expand into adjacent fast-growing markets to sustain its future growth through its R&D effort and acquisitions.
1 in 2 people will be diagnosed with cancer in their lifetime and nearly half of cancer patients have radiation therapy at some point during their cancer treatment. Read more …